Published in Hepatitis Weekly, February 14th, 2000
"The purpose of this study was to evaluate the tolerance and immunogenicity of a hepatitis A vaccine using immunopotentiating reconstituted influenza virosomes (IRIV) as adjuvant when administered simultaneously with a yellow fever vaccine (YFV)," reported P. A. Bovier and colleagues, University Hospital of Geneva, Switzerland.
Bovier et al. published their study in the Journal of Travel Medicine ("Tolerance and Immunogenicity of the Simultaneous Administration of Virosome Hepatitis A...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.